Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1221-1230 of 1,472) with videos related to

Pageof 148
Sort By:
ESMO Open|January 1, 2026
Immune checkpoint blockade in locally advanced rectal cancer with deficient DNA mismatch repair: retrospective multicenter experienceO E Emiloju, N R Foster, P Shah, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2017
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer ChemopreventionDavid S Weinberg, Jieru E Lin, Nathan R Foster, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance)Claire L Jansson-Knodell, Nathan R Foster, Daniel J Sargent, et al.
Journal of Viral Hepatitis|November 21, 2017
Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyA Brown, C Hézode, E Zuckerman, et al.
Clinical Medicine (London, England)|June 3, 2016
Randomised controlled trial of GP-led in-hospital management of homeless people ('Pathway')Nigel Hewett, Peter Buchman, Jeflyn Musariri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2025
Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetesAldara Martin Alonso, Carl J May, Holly Stowell-Connolly, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|April 1, 2025
Defining Priorities for Canadian PICU Family Presence Policies Under Changing Contexts: A Qualitative Focus Group StudyKarla D Krewulak, Jennifer R Foster, Laurie A Lee, et al.
American Journal of Public Health|November 1, 1987
An outbreak of watermelon-borne pesticide toxicityM A Green, M A Heumann, H M Wehr, et al.
Journal of Hepatology|October 30, 2001
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre studyS Caronia, M F Bassendine, R Barry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Pageof 148

Showing results (1221-1230 of 1,472) with videos related to

Sort By:
Pageof 148
ESMO Open|January 1, 2026
Immune checkpoint blockade in locally advanced rectal cancer with deficient DNA mismatch repair: retrospective multicenter experienceO E Emiloju, N R Foster, P Shah, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2017
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer ChemopreventionDavid S Weinberg, Jieru E Lin, Nathan R Foster, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance)Claire L Jansson-Knodell, Nathan R Foster, Daniel J Sargent, et al.
Journal of Viral Hepatitis|November 21, 2017
Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyA Brown, C Hézode, E Zuckerman, et al.
Clinical Medicine (London, England)|June 3, 2016
Randomised controlled trial of GP-led in-hospital management of homeless people ('Pathway')Nigel Hewett, Peter Buchman, Jeflyn Musariri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2025
Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetesAldara Martin Alonso, Carl J May, Holly Stowell-Connolly, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|April 1, 2025
Defining Priorities for Canadian PICU Family Presence Policies Under Changing Contexts: A Qualitative Focus Group StudyKarla D Krewulak, Jennifer R Foster, Laurie A Lee, et al.
American Journal of Public Health|November 1, 1987
An outbreak of watermelon-borne pesticide toxicityM A Green, M A Heumann, H M Wehr, et al.
Journal of Hepatology|October 30, 2001
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre studyS Caronia, M F Bassendine, R Barry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Pageof 148